keep The Value Added Tax (Drugs and Medicines) Order 2020
The Value Added Tax (Drugs and Medicines) Order 2020 modifies Schedule 8 of the VAT Act 1994 to extend zero-rating eligibility for drugs and medicines to supplies prescribed by EEA health professionals (before Brexit) and approved country health professionals (after Brexit). It coordinates VAT treatment timing with IP completion day, ensuring continuity of zero-rating for prescription medicines across different regulatory frameworks.
This regulation extends VAT zero-rating to medicines prescribed by additional categories of health professionals, reducing costs for consumers and increasing access to healthcare. Removing it would raise prices for life-saving medicines and create arbitrary restrictions based on where a health professional qualified. Zero-rating is a pro-competitive policy that benefits lower-income patients most, and the expanded definitions simply ensure prescribers are appropriately qualified without creating monopolies or restricting supply.